Triple-negative breast cancer (TNBC) is characterized by the absence of expression of the ER and PR by immunohistochemistry (IHC) and human epidermal growth factor receptor overexpression absence either by IHC or absence of amplification by fluorescence in-situ hybridization. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.